New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for young people with obesity grows among families and doctors.
According to an analysis by health data firm Truveta, the average rate of teenagers starting treatment with the highly effective Novo Nordisk drug increased by 50 per cent in 2024, reaching 14.8 prescriptions per 100,000 adolescents.
